Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.78% |
| 2 | Healthcare | 3.27% |
| 3 | Industrials | 2.02% |
| 4 | Financials | 2.02% |
| 5 | Consumer Discretionary | 1.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3226
Goldman Sachs MarketBeta International Equity ETF
GSID
$1.13B
| $6.08M | ﹤0.01% |
115,615
+46,090
| +66% | +$2.25M |
|
|
MGLN
3227
DELISTED
Magellan Health Services, Inc.
MGLN
| $6.08M | ﹤0.01% |
73,381
+54,901
| +297% | +$4.34M |
|
3228
CALL
Quest Diagnostics
DGX
$25.9B
| $6.08M | ﹤0.01% |
51,000
-53,000
| -51% | -$6.46M |
|
|
CS
3229
CALL
DELISTED
Credit Suisse Group
CS
| $6.07M | ﹤0.01% |
474,400
+99,300
| +26% | +$1.15M |
|
3230
CALL
Sturm, Ruger & Co
RGR
$602M
| $6.07M | ﹤0.01% |
93,300
-68,200
| -42% | -$4.39M |
|
3231
CALL
iShares Gold Trust
IAU
$64.9B
| $6.07M | ﹤0.01% |
167,350
+5,850
| +4% | +$209K |
|
|
FITB
3232
PUT
Fifth Third Bancorp
FITB
$52.7B
| $6.06M | ﹤0.01% |
219,800
-200,700
| -48% | -$5.07M |
|
3233
CALL
Invesco S&P 500 Equal Weight ETF
RSP
$100B
| $6.06M | ﹤0.01% |
47,500
-29,300
| -38% | -$3.48M |
|
3234
PUT
Corpay
CPAY
$27.4B
| $6.06M | ﹤0.01% |
22,200
+10,200
| +85% | +$2.62M |
|
3235
CALL
Vanguard Morningstar Mega Cap Growth ETF
MGK
$33.9B
| $6.05M | ﹤0.01% |
148,500
+96,000
| +183% | +$3.72M |
|
3236
PUT
LyondellBasell Industries
LYB
$20.6B
| $6.05M | ﹤0.01% |
66,000
-89,300
| -58% | -$7.27M |
|
|
PMVC
3237
DELISTED
PMV Consumer Acquisition Corp.
PMVC
| $6.05M | ﹤0.01% |
+595,708
| New | +$5.88M |
|
3238
PUT
Acadia Pharmaceuticals
ACAD
$4.87B
| $6.04M | ﹤0.01% |
113,000
-23,900
| -17% | -$1.19M |
|
3239
NMI Holdings
NMIH
$3.44B
| $6.03M | ﹤0.01% |
266,408
+233,065
| +699% | +$5.31M |
|
|
NGA
3240
DELISTED
Northern Genesis Acquisition Corp.
NGA
| $6.03M | ﹤0.01% |
+339,224
| New | +$4.15M |
|
3241
ADT
ADT
$5.47B
| $6.02M | ﹤0.01% |
767,382
+695,535
| +968% | +$5.46M |
|
3242
CALL
Trane Technologies
TT
$106B
| $6.01M | ﹤0.01% |
41,400
+19,400
| +88% | +$2.68M |
|
3243
CALL
Agilent Technologies
A
$41.9B
| $6.01M | ﹤0.01% |
50,700
-69,900
| -58% | -$7.73M |
|
3244
nLIGHT
LASR
$3.03B
| $6.01M | ﹤0.01% |
183,950
+98,743
| +116% | +$2.8M |
|
3245
PUT
Iovance Biotherapeutics
IOVA
$3.16B
| $6M | ﹤0.01% |
129,400
+88,400
| +216% | +$3.51M |
|
3246
iShares MSCI Sweden ETF
EWD
$587M
| $6M | ﹤0.01% |
150,781
+138,871
| +1,166% | +$5.26M |
|
3247
PUT
Omega Healthcare
OHI
$14.1B
| $6M | ﹤0.01% |
165,200
-46,400
| -22% | -$1.57M |
|
3248
ICF International
ICFI
$1.59B
| $6M | ﹤0.01% |
80,706
+36,613
| +83% | +$2.63M |
|
3249
FT Vest US Equity Deep Buffer ETF February
DFEB
$464M
| $6M | ﹤0.01% |
+185,217
| New | +$5.86M |
|
3250
PUT
Lear
LEA
$8.32B
| $6M | ﹤0.01% |
37,700
+23,700
| +169% | +$3.33M |
|
Similar funds
Ken Griffin's Q4 2020 Portfolio in Review
As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.
- Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Ken Griffin opened 1,988 new positions and closed 1,130 in Q4 2020.
- Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.